Rezolute Reports First Quarter Fiscal 2023 Financial Results and Highlights Recent Company Progress
REDWOOD CITY, Calif., Nov. 12, 2023 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases associated with chronic glucose imbalance, today announced its financial results for the first quarter of fiscal 2023…